Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
UPI > SEC Filings for UPI > Form 8-K on 12-Aug-2013All Recent SEC Filings

Show all filings for UROPLASTY INC

Form 8-K for UROPLASTY INC


12-Aug-2013

Change in Directors or Principal Officers, Financial Statements and Exhibits


Item 5.02. Departure of Directors and Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

(c) On August 12, 2013, Brett A. Reynolds was appointed Senior Vice President and Chief Financial Officer of Uroplasty, Inc. ("Uroplasty"). From 2005 until its acquisition by Baxter International Inc. in February 2012, Mr. Reynolds, age 44, was the Chief Financial Officer, Vice President of Finance and Corporate Secretary of Synovis Life Technologies, Inc., a publicly-held medical device manufacturer headquartered in the Twin Cities. From 2012 until becoming an officer of Uroplasty, Mr. Reynolds was the site leader of Baxter in the Twin Cities responsible for the remainder of the Synovis operations.

Under his employment agreement with Uroplasty, and in addition to other employment benefits, Mr. Reynolds is entitled to an annual salary of $240,000 per year, participation in Uroplasty's management incentive plan, and the grant of an option to purchase 100,000 shares of common stock, and of 50,000 shares of restricted stock, on the date he was appointed. The options and the restricted stock vest with respect to one-third of the shares on the first, second and third anniversaries of his appointment.

A press release announcing Mr. Reynolds appointment is furnished as Exhibit 99.1.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

10.1 Employment Agreement between Uroplasty, Inc. and Brett A Reynolds dated July 25, 2013.

99.1 Press Release dated August 12, 2013.

  Add UPI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for UPI - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.